[CH3:1][N:2]1[C:11]2[C:6](=[CH:7][C:8](B3OC(C)(C)C(C)(C)O3)=[CH:9][CH:10]=2)[CH2:5][CH2:4][C:3]1=[O:21].Br[C:23]1[C:24]([CH3:37])=[C:25]([CH2:29][NH:30][S@@:31]([C:33]([CH3:36])([CH3:35])[CH3:34])=[O:32])[CH:26]=[N:27][CH:28]=1>>[CH3:37][C:24]1[C:23]([C:8]2[CH:7]=[C:6]3[C:11](=[CH:10][CH:9]=2)[N:2]([CH3:1])[C:3](=[O:21])[CH2:4][CH2:5]3)=[CH:28][N:27]=[CH:26][C:25]=1[CH2:29][NH:30][S@@:31]([C:33]([CH3:36])([CH3:35])[CH3:34])=[O:32]In analogy to the procedure described for the preparation of example 45, 1-methyl-6-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-3,4-dihydro-1H-quinolin-2-one (intermediate A-1) has been coupled to (R)-2-methyl-propane-2-sulfinic acid (5-bromo-4-methyl-pyridin-3-ylmethyl)-amide (intermediate A-59) to give the title compound as a colorless amorphous solid. MS: 386.5 (M+H+).
Loading…